Oral Lichen Planus: Clinical Trials

26 trials for Oral Lichen Planus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 unknown, 2 recruiting, 1 active not recruiting. 26 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 226Completed 16, Unknown 3, Recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 12Completed 1, Enrolling by invitation 1
Phase 32Active not recruiting 1, Completed 1

Follow Oral Lichen Planus: new trials by email Literature Review of Oral Lichen Planus trials Research Report on Oral Lichen Planus

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
5-Amino Levulinic Acid - Oral Cancer, Oral Cavity Cancer
Phase 2Not yet recruitingUniversity of Massachusetts, Boston652026-09-012026-03-19
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus
Topical Bromelain, 0.1% topical triamcinolone acetonide, Combination of Topical Bromelain and Triamcinolone Acetonide in Orabase - Oral Lichen Planus
Phase 2RecruitingCairo University422026-02-182026-06-09
Thyme Honey for Management of Oral Lichen Planus
thyme honey, Triamcinolone Acetonide - Oral Lichen Planus
Phase 1 / Phase 2Enrolling by invitationBritish University In Egypt302024-10-122025-02-06
Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus
Clobetasol Patch, Clobetasol + Resveratrol Patch, Clobetasol in Orabase - Oral Lichen Planus, Oral Lichen Planus Related Stress
Phase 2RecruitingUniversity of Palermo452024-09-042025-08-03
Evaluating LP-10 in Subjects With OLP
LP-10 (Liposomal Tacrolimus) - Oral Lichen Planus
Phase 2UnknownLipella Pharmaceuticals, Inc.242024-07-012025-05-15
Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study
Baricitinib 4 milligram Oral Tablet - Lichen Planus, Oral, Lichen Planus, Mucosal
Phase 2CompletedUniversity of North Carolina, Chapel Hill102024-03-132026-10-30
A Comparison of Photodynamic Therapy and Topical Clobetasol in Treatment of Oral Lichen Planus: a Split-Mouth Randomised Controlled Study
Photodynamic Therapy, Clobetasol - Oral Lichen Planus
Phase 2CompletedWroclaw Medical University292023-06-012024-12-30
Evaluation of Efficacy of Neem (Azadirachta Indica) Versus Triamcinolone Acetonide in the Treatment of Oral Lichen Planus.
Neem gel, Triamcinolone Acetonide - Oral Lichen Planus
Phase 1 / Phase 2CompletedGoa Dental College602023-02-052025-09-03
Dexamethasone Solution and Dexamethasone in Mucolox™
dexamethasone 0.5mg/5ml solution, dexamethasone 0.5mg/5ml solution in Mucolox™ - Oral Lichen Planus, Mucous Membrane Pemphigoid
Phase 2CompletedUniversity of California, San Francisco292020-12-262023-12-15
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
Clobetasol Propionate, Placebo/Klobetasol APL oral gel 0.025%, Placebo - Oral Lichen Planus
Phase 2 / Phase 3Active not recruitingMalmö University902020-05-182024-12-04
Evaluation of the Effectiveness of Photodynamic Therapy in the Treatment of Lesions of the Lichen Planus Type in the Oral Mucosa and Its Diagnostics With the Use of Autofluorescence, in Various Wavelength Ranges, in Combination With the Use of Texture Analysis and Fractal Dimension
PDT Therapy, Triamcinolone (Substance) therapy side - Oral Lichen Planus
Phase 2CompletedWroclaw Medical University302020-02-082021-08-05
Apremilast - Oral Lichen Planus Trial
Apremilast, Placebo - Oral Lichen Planus
Phase 2WithdrawnSunnybrook Health Sciences Centre2019-11-212020-06-25
Intra-oral Treatment of OLP With Rivelin®-CLO Patches
Clobetasol Propionate - Oral Lichen Planus
Phase 2CompletedDermtreat1402018-06-282020-07-14
Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions.
Ibuprofen suspension 5mg/100ml, Placebos - Oral Lichen Planus, Oral Lichenoid Mucositis
Phase 2 / Phase 3CompletedUniversity of Washington232018-04-292020-05-08
Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus
Bifidobacterium animalis subsp. lactis HN019, Clobetasol propionate 0.05% - Oral Lichen Planus
Phase 2CompletedUniversity of Sao Paulo222017-11-062020-03-27
Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus
Betamethasone Dipropionate, Clobetasol Propionate - Oral Lichen Planus
Phase 2UnknownGarlapati Komali302016-05-062018-03-14
Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus
Tacrolimus 0.1%, Clobetasol 0.05% - Oral Lichen Planus
Phase 2CompletedUniversity of Peradeniya682014-06-012016-04-20
Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus
Licorice, Triamcinolone Acetonide - Oral Lichen Planus
Phase 2CompletedIsfahan University of Medical Sciences602014-01-012015-05-25
The Efficacy of Omega-3 in Treatment of Atrophic/Erosive Lichen Planus
Prednisone tablet 5mg, Omega-3 soft capsules 1000 mg - Oral Lichen Planus
Phase 2CompletedOctober 6 University302013-05-012015-04-28
Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases
NAVS Naphthalan, 0.05% Betamethasone dipropionate - Oral Lichen Planus, Recurrent Aphthous Stomatitis
Phase 2CompletedIvan Alajbeg572010-12-012016-09-30

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Lichen Planus, Oral (26)  ·  Lichen Planus (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Carcinoma in Situ (1)  ·  Leukoplakia, Oral (1)  ·  Mouth Neoplasms (1)  ·  Oral Ulcer (1)  ·  Pemphigoid, Benign Mucous Membrane (1)  ·  Pemphigus (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomatitis, Aphthous (1)  ·  Torulopsis (1)  ·  Ulcer (1)

Broader conditions

Lichenoid Eruptions (26)  ·  Mouth Diseases (26)  ·  Skin Diseases (26)  ·  Skin Diseases, Papulosquamous (26)  ·  Skin and Connective Tissue Diseases (26)  ·  Stomatognathic Diseases (26)  ·  Lichen Planus (24)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Autoimmune Diseases (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)

Interventions

Clobetasol (5)  ·  Triamcinolone Acetonide (4)  ·  Dexamethasone (2)  ·  Diarylheptanoids (2)  ·  Orabase (2)  ·  Photochemotherapy (2)  ·  Solutions (2)  ·  Triamcinolone (2)  ·  betamethasone-17,21-dipropionate (2)  ·  Adrenal Cortex Hormones (1)  ·  Aminolevulinic Acid (1)  ·  Bromelains (1)  ·  Doxycycline (1)  ·  Gels (1)  ·  Glycyrrhiza glabra extract (1)

Sponsors

Mashhad University of Medical Sciences (2)  ·  University of California, San Francisco (2)  ·  Wroclaw Medical University (2)  ·  British University In Egypt (1)  ·  Cairo University (1)  ·  Dermtreat (1)  ·  Garlapati Komali (1)  ·  Goa Dental College (1)  ·  Isfahan University of Medical Sciences (1)  ·  Ivan Alajbeg (1)  ·  Lipella Pharmaceuticals, Inc. (1)  ·  Malmö University (1)  ·  National Institute of Dental and Craniofacial Research (NIDCR) (1)  ·  Nita Chainani Wu (1)  ·  October 6 University (1)

Countries

United States (9)  ·  Egypt (3)  ·  India (3)  ·  Canada (2)  ·  Iran (2)  ·  Poland (2)  ·  Brazil (1)  ·  Croatia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Alessandro Villa, DDS, PhD, MPH (1)  ·  Arash Mansourian, DDS,MS (1)  ·  Christopher Hull, MD (1)  ·  Donna Culton, MD, PhD (1)  ·  Ellen E Monteiro, Student (1)  ·  Enas Elgendy, ph.D (1)  ·  Fatemeh Momen Heravi (1)  ·  Gilberto A Silva, MS (1)  ·  Hagen Klieb, HBSc, MSc, DMD, FRCD(C) (1)  ·  Ivan Alajbeg, PhD (1)  ·  Jonathan Celli, PhD (1)  ·  Kleber Tanaka Suzuki, DDS (1)

Results publications

PMID 18155609, PMID 21175873, PMID 21907450, PMID 33831097, PMID 37549933, PMID 41174333, PMID 42163196

NIH funding

U01CA279862 (1)